Accrued expenses (Details) - Veraxa Biotech A G [Member] - CHF (SFr) |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Entity Information [Line Items] | ||
| Personnel expenses | SFr 459,669 | SFr 253,718 |
| Tax provision (incl. emission levies on capital band) | 535,548 | 427,592 |
| Xlife share lending accrual | 1,189,037 | 1,001,878 |
| Other | 491,369 | 119,162 |
| Total accrued expenses | SFr 2,675,623 | SFr 1,802,350 |